Transactions
Innoviva, Inc.’s sale of its 15% stake Theravance Respiratory Company LLC to Royalty Pharma plc
Date Announced:
07/13/2022
client:
Innoviva, Inc.
Status:
Closed – 07/13/2022
Value:
$282 million plus a $50m milestone payment, and full retention of existing equity investments
